BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15162426)

  • 1. Ultra-sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cells.
    Barnes E; Ward SM; Kasprowicz VO; Dusheiko G; Klenerman P; Lucas M
    Eur J Immunol; 2004 Jun; 34(6):1570-7. PubMed ID: 15162426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; Wright TL; Greenberg HB
    J Immunol Methods; 2004 Apr; 287(1-2):91-9. PubMed ID: 15099758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
    Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
    J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
    Abel M; Sène D; Pol S; Bourlière M; Poynard T; Charlotte F; Cacoub P; Caillat-Zucman S
    Hepatology; 2006 Dec; 44(6):1607-16. PubMed ID: 17133491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction of HLA-A2-peptide tetramer and application in HBV/HCV infection].
    Piao WH; He Y; Xi HL; Sun XT; Zhang HH; Xu JH; Zhao H; Xu WX; Li ZL; Wang GQ
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1818-22. PubMed ID: 15631781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.
    Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R
    Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors.
    Scognamiglio P; Accapezzato D; Casciaro MA; Cacciani A; Artini M; Bruno G; Chircu ML; Sidney J; Southwood S; Abrignani S; Sette A; Barnaba V
    J Immunol; 1999 Jun; 162(11):6681-9. PubMed ID: 10352286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection.
    Boni C; Amadei B; Urbani S; Fisicaro P; Zerbini A; Mori C; Missale G; Bertoni R; Azzurri A; Del Prete G; Ferrari C
    Hepatology; 2004 Aug; 40(2):289-99. PubMed ID: 15368433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.
    Urbani S; Amadei B; Fisicaro P; Tola D; Orlandini A; Sacchelli L; Mori C; Missale G; Ferrari C
    Hepatology; 2006 Jul; 44(1):126-39. PubMed ID: 16799989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
    Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF
    J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual demonstration of hepatitis C virus-specific memory CD8(+) T-cell expansion in patients with acute hepatitis C.
    Sobao Y; Tomiyama H; Nakamura S; Sekihara H; Tanaka K; Takiguchi M
    Hepatology; 2001 Jan; 33(1):287-94. PubMed ID: 11124847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes.
    Komatsu H; Lauer G; Pybus OG; Ouchi K; Wong D; Ward S; Walker B; Klenerman P
    J Viral Hepat; 2006 Feb; 13(2):121-30. PubMed ID: 16436130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
    J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of HCV antigens to naive CD8+T cells: why the where, when, what and how are important for virus control and infection outcome.
    Racanelli V; Manigold T
    Clin Immunol; 2007 Jul; 124(1):5-12. PubMed ID: 17540619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
    Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
    J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response.
    Pilli M; Penna A; Zerbini A; Vescovi P; Manfredi M; Negro F; Carrozzo M; Mori C; Giuberti T; Ferrari C; Missale G
    Hepatology; 2002 Dec; 36(6):1446-52. PubMed ID: 12447871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus mutation affects proteasomal epitope processing.
    Seifert U; Liermann H; Racanelli V; Halenius A; Wiese M; Wedemeyer H; Ruppert T; Rispeter K; Henklein P; Sijts A; Hengel H; Kloetzel PM; Rehermann B
    J Clin Invest; 2004 Jul; 114(2):250-9. PubMed ID: 15254592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
    Semmo N; Krashias G; Willberg C; Klenerman P
    J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.